Clinical Trial Update: Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 dose-escalation trial evaluating corticosteroids and surfactant in extremely low gestational age infants with Bronchopulmonary Dysplasia was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Corticosteroid (corticosteroid)
• Surfactant (surfactant)

Snippet

Sponsor: Cynthia McEvoy | Conditions: Bronchopulmonary Dysplasia (BPD) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-04-04